after earnings

#STLA Stellantis = +5%
#BIDU Baidu = -6%
#IQ iQIYI = -5%
#VIPS Vipshop = +1%
#DNUT Krispy Kreme = +30%
#QBTS D-Wave Quantum = +4%
#PZZA Papa Johns = -4%
#PENN Penn Entertainment = +10%
#HTZ Hertz = -1%
#NVAX Novavax = +20%

📢 Stocks Trending NOW: #NVDA #IONQ #EOSE #NVAX #TTD #CELH #QBTS #STLA #RXT #CRM

Pfizer, Sanofi deals give Novavax shot at billions in vaccine revenue Net income swung to $440M on $1.1B 2025 revenue, as Novavax cut R&D and SG&A sharply and lined up a $30M Pfizer deal plus $225M in Sanofi milestones.

#NVAX Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

www.stocktitan.net/news/NVAX/novavax-report...

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know. www.zacks.com/stock/news/2... #NVAX

#NVAX #04219763-b928-48b1-ab05-bde9eaaefbfd #investing #Health #Care

Origin | Interest | Match

#NVAX gets another vaccine deal with Pfizer, boosting short squeeze potential and institutional support.

Novavax Announces Entering into a License Agreement with Pfizer Novavax (NASDAQ: NVAX) announced a non-exclusive license agreement with Pfizer dated January 20, 2026 for use of Novavax's Matrix-M® adjuvant in up to two disease areas. Novavax will receive a $30 million upfront payment and is eligible for up to $500 million in development and sales milestones plus tiered high mid-single digit percent royalties on sales of Pfizer products containing Matrix-M. Pfizer will be solely responsible for development and commercialization of its Matrix-M–containing products, while Novavax will supply Matrix-M for Pfizer's programs.

#NVAX Novavax Announces Entering into a License Agreement with Pfizer

www.stocktitan.net/news/NVAX/novavax-announ...

📢 Stocks Trending NOW: #JPM #DAL #NVAX #EVTV #ATON #LHX #AMD #AHMA #BCTX #BBY

Leading Indicators, Wednesday January 7, 2026 – Crystal Equity Research

Small-cap stocks in new uptrend according to average directional index, Wed Jan 7th - #QUIK #SDA #WLDN #ZNTL #AEVA #BACQ #DTI #ESQ #HYFT #ICHR #LUCD #NVAX #PGEN #SB #OGN #NSP #LPG #IHD #FC #EBS #CYD #BKSY - More: crystalequityresearch.com/leading-indi... - #smallcap

🚨 Institutions #optionsvolume surge detected! PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #ARES 20.9x
2. #XEL 10.4x
3. #CGON 7.2x
4. #NVAX 7.0x
5. #PZZA 6.1x

#OptionFlow #OptionsTrading #Trading

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#XEL, #CGON, #NVAX, #PZZA, #PBR

#OptionFlow #OptionsTrading #Trading

🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus

🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#AMZN, #XEL, #CGON, #BE, #NVAX

#OptionFlow #OptionsTrading #Trading

Equivox — Empowering Retail Shareholders Equivox is the platform for retail investors to coordinate, discuss, and drive real change in the companies they own.

Shah Capital puts pressure on #NVAX

www.equivox.io/discussion/1...

💉 #MRNA and #NVAX fell ~6% and ~4% after reports that an internal FDA memo said at least 10 child deaths were likely related to COVID-19 vaccinations. The memo didn’t specify which vaccines, and data isn’t public. The FDA says it will tighten future vaccine-approval standards.

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#SVRA, #DOCN, #UPWK, #ON, #NVAX

#OptionFlow #OptionsTrading #Trading

🚨 Institutions #optionsvolume surge detected! AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #DOCN 5.5x
2. #NVAX 3.4x
3. #TOST 3.0x
4. #HALO 2.9x
5. #ON 2.5x

#OptionFlow #OptionsTrading #Trading

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#DOCN, #NVAX, #ON, #LAZ, #CMBT

#OptionFlow #OptionsTrading #Trading

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#PAAS, #NVAX, #CGBD, #CTSH, #XNET

#OptionFlow #OptionsTrading #Trading

🚨 Institutions #optionsvolume surge detected! AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #SGRY 3.7x
2. #PAAS 3.3x
3. #NVAX 2.6x
4. #CGBD 2.6x
5. #KSS 2.2x

#OptionFlow #OptionsTrading #Trading

after earnings

#AZN Astrazeneca = +3.5%
#YETI Yeti = +4%
#GOOS Canada Goose = -15%
#DNUT Krispy Kreme = +10%
#UAA Under Armor = -3%
#COP ConocoPhillips = -1%
#MRNA Moderna = +4%
#WBD Warner Bros = 0%
#PZZA Papa Johns = +5%
#PENN Penn Entertainment = -5%
#NVAX Novavax = 0%

📢 Stocks Trending NOW: #DUOL #MRVL #SNAP #MRNA #CELH #NVAX #DDOG #CRK #OSCR #DKNG

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights Novavax (NASDAQ: NVAX) reported Q3 2025 total revenue of $70M versus $85M a year earlier and a net loss of $202M. The company earned $225M in Sanofi milestones year‑to‑date, including $50M in Q4 2025 related to marketing authorization transfers. Cash totaled $778M as of September 30, 2025.Key items: R&D $98M with $46M reimbursed by Sanofi; non‑cash charges $126M (including $97M impairment and $29M debt extinguishment loss); Maryland consolidation yields $60M cash and ~$230M expected savings over 11 years. Full‑year adjusted revenue framework raised to $1,040–$1,060M.

#NVAX Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

www.stocktitan.net/news/NVAX/novavax-report...

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment Novavax (Nasdaq: NVAX) completed transfer of U.S. marketing authorization for its COVID-19 vaccine Nuvaxovid to Sanofi after receiving U.S. BLA approval, enabling Sanofi to assume U.S. commercial and regulatory responsibility.The transfer triggered a second $25 million milestone payment and follows an October 2025 EU transfer, contributing to $225 million of non-dilutive milestone revenue secured year-to-date 2025. Novavax remains eligible for additional milestone payments and royalties under the collaboration and license agreement related to Nuvaxovid, combination products and Matrix-M adjuvant use.

#NVAX Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

www.stocktitan.net/news/NVAX/novavax-comple...

#NVAX 9C for April.

Novavax Completes Convertible Debt Refinancing to Improve Capital Structure Novavax, Inc. has announced a convertible debt refinancing plan worth $225 million, extending maturity dates and enhancing financial terms.

Novavax Completes Convertible Debt Refinancing to Improve Capital Structure #United_States #Novavax #Gaithersburg #Convertible_Debt #NVAX

Novavax Announces Convertible Debt Refinancing Novavax (NASDAQ:NVAX) has announced a significant debt refinancing transaction involving its convertible notes. The company will issue $225 million of 4.625% Convertible Senior Notes due 2031, comprising $175.3 million in exchange for existing 2027 Notes and $49.7 million in new funding.The 2031 Notes will have an initial conversion price of $11.14 per share, representing a 27.5% premium over the August 20, 2025 closing price. After the transaction's completion, expected around August 27, 2025, $26.5 million of the 2027 Notes will remain outstanding, while the new 2031 Notes will total $225 million.

#NVAX Novavax Announces Convertible Debt Refinancing

www.stocktitan.net/news/NVAX/novavax-announ...

NVAX Novavax Announces Preclinical Data Demonstrating That Novavax's H5n1 Avian Pandemic Influenza Vaccine Candidate Induced Robust Immune Responses By Either Single Or Two-Dose Intranasal Or Intramuscular Administration In Nonhuman Primates. #NVAX

#CGC #NVAX #1c64e068-e1bd-454c-a100-0e88c5d35174 #investing

Origin | Interest | Match

Good Morning!

Futures down.. very quiet this am

#NVDA pt raised $200 from $170 @ Barclays

#NVAX int Sell @ Citi pt $6

#ROKU u/g Buy @ Loop pt $100 from $80

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Most searched small-cap stocks, Tue May 20th - #WULF #NRXS #RIG #TDOC #SYTA #QUBT #QMCO #NVAX #MGNX #LEU #KULR #IQ #HUT #FTRE #ESPR #DAWN #CGC #CERS #ATER #ASST - More: crystalequityresearch.com/SmCpStr/ - #smallcap